Cargando…
A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence
Coronavirus disease 2019 (COVID-19) caused by a novel human coronavirus has led to a tsunami of viral illness across the globe, originating from Wuhan, China. Although the value and effectiveness of extracorporeal membrane oxygenation (ECMO) in severe respiratory illness from COVID-19 remains unclea...
Autores principales: | Rajdev, Kartikeya, Farr, Lyndie A., Saeed, Muhammad Ahsan, Hooten, Rorak, Baus, Joseph, Boer, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488892/ https://www.ncbi.nlm.nih.gov/pubmed/32911986 http://dx.doi.org/10.1177/2324709620957778 |
Ejemplares similares
-
Extracorporeal membrane oxygenation for acute respiratory distress syndrome
por: Aokage, Toshiyuki, et al.
Publicado: (2015) -
Inter-hospital transport of severe acute respiratory distress syndrome on extracorporeal membrane oxygenation: Extracorporeal membrane oxygenation retrieval
por: Kumar, Raj, et al.
Publicado: (2016) -
Longtime Neurologic Outcome of Extracorporeal Membrane Oxygenation and Non Extracorporeal Membrane Oxygenation Acute Respiratory Distress Syndrome Survivors
por: Harnisch, Lars-Olav, et al.
Publicado: (2019) -
EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?
por: Sameed, Muhammad, et al.
Publicado: (2019) -
Venovenous Extracorporeal Membrane Oxygenation for Postoperative Acute Respiratory Distress Syndrome
por: Seo, Dong Ju, et al.
Publicado: (2015)